In vivo pharmacology models are essential for developing and optimising new therapeutic agents, offering critical insights into a drug's efficacy, safety and pharmacokinetics. By conducting experiments within living organisms, we provide invaluable data on drug interactions with biological systems. These insights help you make informed decisions, optimise treatment strategies and accelerate the path from the lab to the clinic.
As an AAALAC-certified contract research organisation, we offer in vivo studies to accelerate your compounds toward clinical application. Our expert teams support integrated drug discovery programs with comprehensive in vivo characterisation and advanced ex vivo analysis. Using a variety of animal models and platforms across multiple indications, we help enhance the value of each study.
We are constantly expanding our hiPSC-derived cell portfolio in the cardiology and neurology indication spaces.
Learn moreEnhance drug development success with ex vivo tissue models, focusing on primary cell assays that provide translational value in drug discovery.
Learn MoreDiscover how we can support you in your efforts to understand the pharmacokinetics of your drug with our in vivo DMPK services.
Learn more